Brokerages expect Addus HomeCare Corporation (NASDAQ:ADUS) to report $110.82 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Addus HomeCare’s earnings. The lowest sales estimate is $110.15 million and the highest is $111.50 million. Addus HomeCare posted sales of $103.66 million in the same quarter last year, which indicates a positive year-over-year growth rate of 6.9%. The firm is scheduled to report its next quarterly earnings results on Monday, March 5th.

On average, analysts expect that Addus HomeCare will report full year sales of $110.82 million for the current fiscal year, with estimates ranging from $423.91 million to $425.30 million. For the next financial year, analysts anticipate that the business will report sales of $453.58 million per share, with estimates ranging from $452.70 million to $454.46 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for Addus HomeCare.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.04. The company had revenue of $108.60 million for the quarter, compared to analyst estimates of $108.99 million. Addus HomeCare had a net margin of 4.30% and a return on equity of 10.35%. Addus HomeCare’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter last year, the business earned $0.39 EPS.

A number of equities analysts have weighed in on the stock. Zacks Investment Research lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Friday, August 18th. Robert W. Baird reiterated a “hold” rating and issued a $40.00 price target on shares of Addus HomeCare in a report on Thursday, August 24th. Finally, Oppenheimer reiterated a “buy” rating and issued a $45.00 price target on shares of Addus HomeCare in a report on Tuesday, September 19th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $41.33.

Addus HomeCare (NASDAQ ADUS) opened at $32.20 on Tuesday. The firm has a market cap of $385.01, a price-to-earnings ratio of 22.36, a price-to-earnings-growth ratio of 1.55 and a beta of 0.17. Addus HomeCare has a 1-year low of $29.90 and a 1-year high of $40.75. The company has a quick ratio of 2.68, a current ratio of 2.68 and a debt-to-equity ratio of 0.23.

Several large investors have recently bought and sold shares of ADUS. Vanguard Group Inc. lifted its holdings in shares of Addus HomeCare by 6.3% during the 1st quarter. Vanguard Group Inc. now owns 318,439 shares of the company’s stock valued at $10,190,000 after acquiring an additional 18,913 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Addus HomeCare by 6.9% during the 1st quarter. Geode Capital Management LLC now owns 57,652 shares of the company’s stock valued at $1,844,000 after acquiring an additional 3,740 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Addus HomeCare by 363.4% during the 1st quarter. Renaissance Technologies LLC now owns 57,000 shares of the company’s stock valued at $1,824,000 after acquiring an additional 44,700 shares in the last quarter. Goldman Sachs Group Inc. acquired a new position in shares of Addus HomeCare during the 1st quarter valued at $238,000. Finally, Russell Investments Group Ltd. lifted its holdings in shares of Addus HomeCare by 831.8% during the 2nd quarter. Russell Investments Group Ltd. now owns 300,101 shares of the company’s stock valued at $11,165,000 after acquiring an additional 267,896 shares in the last quarter. Institutional investors and hedge funds own 92.97% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/12/12/addus-homecare-corporation-adus-expected-to-post-quarterly-sales-of-110-82-million.html.

Addus HomeCare Company Profile

Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.

Get a free copy of the Zacks research report on Addus HomeCare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus HomeCare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.